US Stock MarketDetailed Quotes

Grace Therapeutics (GRCE)

Watchlist
  • 3.650
  • +0.010+0.27%
Close Jan 16 16:00 ET
  • 3.540
  • -0.110-3.01%
Post 17:05 ET
56.48MMarket Cap-6.89P/E (TTM)

Grace Therapeutics (GRCE) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Sep 30, 2025
(Q1)Jun 30, 2025
(FY)Mar 31, 2025
(Q4)Mar 31, 2025
(Q3)Dec 31, 2024
(Q2)Sep 30, 2024
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-47.65%2.53M
-37.74%3.09M
46.73%16.68M
-2.45%3.18M
21.72%3.7M
130.93%4.83M
67.16%4.96M
-37.70%11.37M
-21.66%3.26M
-28.32%3.04M
Selling and administrative expenses
5.77%1.96M
-5.37%2.13M
7.78%7.16M
0.26%1.55M
-5.69%1.51M
13.61%1.85M
20.47%2.25M
-19.09%6.64M
-38.67%1.54M
-9.86%1.6M
-Selling and marketing expense
----
----
----
----
----
----
----
42.65%194K
----
----
-General and administrative expense
5.77%1.96M
-5.37%2.13M
7.78%7.16M
0.26%1.55M
-5.69%1.51M
13.61%1.85M
20.47%2.25M
-17.73%6.64M
-37.40%1.54M
-6.05%1.6M
Research and development costs
-80.91%568K
-64.73%955K
103.10%9.51M
-3.03%1.63M
52.04%2.19M
546.96%2.98M
147.31%2.71M
-53.04%4.68M
2.74%1.69M
-41.10%1.44M
Depreciation amortization depletion
-50.00%1K
100.00%2K
-82.50%7K
-94.29%2K
--1K
100.00%2K
-66.67%1K
-36.51%40K
288.89%35K
--0
-Depreciation and amortization
-50.00%1K
100.00%2K
-82.50%7K
-94.29%2K
--1K
100.00%2K
-66.67%1K
-36.51%40K
288.89%35K
--0
Operating profit
47.65%-2.53M
37.74%-3.09M
-46.73%-16.68M
2.45%-3.18M
-21.72%-3.7M
-130.93%-4.83M
-67.16%-4.96M
37.70%-11.37M
21.66%-3.26M
28.32%-3.04M
Net non-operating interest income expense
0.00%172K
-12.77%205K
-21.95%711K
-32.93%167K
-56.33%138K
-18.87%172K
75.37%235K
270.33%911K
122.32%249K
371.64%316K
Non-operating interest income
0.00%172K
-12.77%205K
-21.95%711K
-32.93%167K
-56.33%138K
-18.87%172K
75.37%235K
270.33%911K
122.32%249K
371.64%316K
Other net income (expense)
278.40%1.42M
-134.39%-477K
175.69%3.2M
353.03%2.63M
-1,032.81%-1.19M
120.39%375K
193.91%1.39M
87.55%-4.23M
96.93%-1.04M
753.33%128K
Gain on sale of security
278.40%1.42M
-134.39%-477K
216.65%3.2M
353.03%2.63M
-1,032.81%-1.19M
120.39%375K
17,237.50%1.39M
-4,325.81%-2.74M
-34,800.00%-1.04M
753.33%128K
Special income (charges)
----
----
--0
--0
--0
--0
--0
95.62%-1.49M
--0
--0
-Less:Restructuring and merger&acquisition
----
----
--0
--0
--0
--0
--0
--1.49M
--0
--0
-Less:Impairment of capital assets
----
----
----
----
----
----
----
--0
----
----
-Write off
----
----
----
----
----
----
----
--0
----
----
Income before tax
78.10%-938K
-0.63%-3.36M
13.06%-12.77M
90.58%-382K
-83.15%-4.76M
-15.19%-4.28M
22.52%-3.34M
71.74%-14.69M
89.32%-4.06M
37.57%-2.6M
Income tax
0
0
-74.62%-3.2M
-14.51%-1.02M
-190.87%-605K
-91.03%-852K
-150.52%-724K
80.80%-1.83M
89.98%-889K
24.09%-208K
Net income
72.67%-938K
-28.47%-3.36M
25.56%-9.57M
120.09%636K
-73.78%-4.16M
-4.86%-3.43M
34.95%-2.62M
69.71%-12.85M
89.12%-3.17M
38.52%-2.39M
Net income continuous Operations
72.67%-938K
-28.47%-3.36M
25.56%-9.57M
120.09%636K
-73.78%-4.16M
-4.86%-3.43M
34.95%-2.62M
69.71%-12.85M
89.12%-3.17M
38.52%-2.39M
Minority interest income
Net income attributable to the parent company
72.67%-938K
-28.47%-3.36M
25.56%-9.57M
120.09%636K
-73.78%-4.16M
-4.86%-3.43M
34.95%-2.62M
69.71%-12.85M
89.12%-3.17M
38.52%-2.39M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
72.67%-938K
-28.47%-3.36M
25.56%-9.57M
120.09%636K
-73.78%-4.16M
-4.86%-3.43M
34.95%-2.62M
69.71%-12.85M
89.12%-3.17M
38.52%-2.39M
Basic earnings per share
80.00%-0.06
12.50%-0.21
41.48%-0.79
138.46%0.1
-71.43%-0.36
30.23%-0.3
55.56%-0.24
76.36%-1.35
93.35%-0.26
59.62%-0.21
Diluted earnings per share
80.00%-0.06
12.50%-0.21
41.48%-0.79
138.46%0.1
-71.43%-0.36
30.23%-0.3
55.56%-0.24
76.36%-1.35
93.35%-0.26
59.62%-0.21
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Sep 30, 2025(Q1)Jun 30, 2025(FY)Mar 31, 2025(Q4)Mar 31, 2025(Q3)Dec 31, 2024(Q2)Sep 30, 2024(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -47.65%2.53M-37.74%3.09M46.73%16.68M-2.45%3.18M21.72%3.7M130.93%4.83M67.16%4.96M-37.70%11.37M-21.66%3.26M-28.32%3.04M
Selling and administrative expenses 5.77%1.96M-5.37%2.13M7.78%7.16M0.26%1.55M-5.69%1.51M13.61%1.85M20.47%2.25M-19.09%6.64M-38.67%1.54M-9.86%1.6M
-Selling and marketing expense ----------------------------42.65%194K--------
-General and administrative expense 5.77%1.96M-5.37%2.13M7.78%7.16M0.26%1.55M-5.69%1.51M13.61%1.85M20.47%2.25M-17.73%6.64M-37.40%1.54M-6.05%1.6M
Research and development costs -80.91%568K-64.73%955K103.10%9.51M-3.03%1.63M52.04%2.19M546.96%2.98M147.31%2.71M-53.04%4.68M2.74%1.69M-41.10%1.44M
Depreciation amortization depletion -50.00%1K100.00%2K-82.50%7K-94.29%2K--1K100.00%2K-66.67%1K-36.51%40K288.89%35K--0
-Depreciation and amortization -50.00%1K100.00%2K-82.50%7K-94.29%2K--1K100.00%2K-66.67%1K-36.51%40K288.89%35K--0
Operating profit 47.65%-2.53M37.74%-3.09M-46.73%-16.68M2.45%-3.18M-21.72%-3.7M-130.93%-4.83M-67.16%-4.96M37.70%-11.37M21.66%-3.26M28.32%-3.04M
Net non-operating interest income expense 0.00%172K-12.77%205K-21.95%711K-32.93%167K-56.33%138K-18.87%172K75.37%235K270.33%911K122.32%249K371.64%316K
Non-operating interest income 0.00%172K-12.77%205K-21.95%711K-32.93%167K-56.33%138K-18.87%172K75.37%235K270.33%911K122.32%249K371.64%316K
Other net income (expense) 278.40%1.42M-134.39%-477K175.69%3.2M353.03%2.63M-1,032.81%-1.19M120.39%375K193.91%1.39M87.55%-4.23M96.93%-1.04M753.33%128K
Gain on sale of security 278.40%1.42M-134.39%-477K216.65%3.2M353.03%2.63M-1,032.81%-1.19M120.39%375K17,237.50%1.39M-4,325.81%-2.74M-34,800.00%-1.04M753.33%128K
Special income (charges) ----------0--0--0--0--095.62%-1.49M--0--0
-Less:Restructuring and merger&acquisition ----------0--0--0--0--0--1.49M--0--0
-Less:Impairment of capital assets ------------------------------0--------
-Write off ------------------------------0--------
Income before tax 78.10%-938K-0.63%-3.36M13.06%-12.77M90.58%-382K-83.15%-4.76M-15.19%-4.28M22.52%-3.34M71.74%-14.69M89.32%-4.06M37.57%-2.6M
Income tax 00-74.62%-3.2M-14.51%-1.02M-190.87%-605K-91.03%-852K-150.52%-724K80.80%-1.83M89.98%-889K24.09%-208K
Net income 72.67%-938K-28.47%-3.36M25.56%-9.57M120.09%636K-73.78%-4.16M-4.86%-3.43M34.95%-2.62M69.71%-12.85M89.12%-3.17M38.52%-2.39M
Net income continuous Operations 72.67%-938K-28.47%-3.36M25.56%-9.57M120.09%636K-73.78%-4.16M-4.86%-3.43M34.95%-2.62M69.71%-12.85M89.12%-3.17M38.52%-2.39M
Minority interest income
Net income attributable to the parent company 72.67%-938K-28.47%-3.36M25.56%-9.57M120.09%636K-73.78%-4.16M-4.86%-3.43M34.95%-2.62M69.71%-12.85M89.12%-3.17M38.52%-2.39M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 72.67%-938K-28.47%-3.36M25.56%-9.57M120.09%636K-73.78%-4.16M-4.86%-3.43M34.95%-2.62M69.71%-12.85M89.12%-3.17M38.52%-2.39M
Basic earnings per share 80.00%-0.0612.50%-0.2141.48%-0.79138.46%0.1-71.43%-0.3630.23%-0.355.56%-0.2476.36%-1.3593.35%-0.2659.62%-0.21
Diluted earnings per share 80.00%-0.0612.50%-0.2141.48%-0.79138.46%0.1-71.43%-0.3630.23%-0.355.56%-0.2476.36%-1.3593.35%-0.2659.62%-0.21
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More